Perinatal and neonatal manipulation of the intestinal microbiome: A note of caution

Nutrition Reviews

Volumn 65, Issue 6, 2007, Pages 282-285

  Neu, Josef ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antibiotics; Intestine; Microbiome; Neonatal; Perinatal; Prebiotics; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT;

CHILD NUTRITION; IMMUNE SYSTEM; INFANT NUTRITION; INTESTINE FLORA; NEWBORN CARE; NEWBORN PERIOD; NUTRITIONAL ASSESSMENT; PERINATAL CARE; REVIEW; ENTEROPATHY; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFANT; MICROBIOLOGY; NEWBORN; PHYSIOLOGY; SYMBIOSIS;

GASTROINTESTINAL TRACT; HUMANS; INFANT; INFANT NUTRITION PHYSIOLOGY; INFANT, NEWBORN; INTESTINAL DISEASES; PROBIOTICS; SYMBIOSIS;

EID: 34547160424     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2007.jun.282-285     Document Type: Review

References (35)

1. Hooper LV, Midtvedt T., Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002 22 : 283 307.
2. Hooper LV. Bacterial contributions to mammalian gut development. Trends Microbiol 2004 12 (3 129 134.
3. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A. 2002 99 (24 15451 15455.
4. Bourlioux P., Koletzko B., Guarner F., Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. Am J Clin Nutr 2003 78 (4 675 683.
5. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002 347 (12 911 920.
6. Sonnenburg JL, Angenent LT, Gordon JI. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine Nat Immunol 2004 5 (6 569 573.
7. Rook GA, Brunet LR., Microbes, immunoregulation, and the gut. Gut 2005 54 (3 317 320.
8. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004 118 (2 229 241.
9. Benitz WE. Perinatal treatment to prevent early onset group B streptococcal sepsis. Semin Neonatol 2002 7 (4 301 314.
10. Caicedo RA, Schanler RJ, Li N., Neu J. The developing intestinal ecosystem: implications for the neonate. Pediatr Res 2005 58 (4 625 628.
11. Favier CF, Vaughan EE, De Vos WM, Akkermans ADL. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002 68 (1 219 226.
12. Kalliomaki M., Salminen S., Poussa T., Arvilommi H., Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003 361 (9372 1869 1871.
13. Lodinová-Zádníková R., Cukrowska B., Tlaskalova-Hogenova H. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 2003 131 : 209 211.
14. Sudo N., Chida Y., Aiba Y., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice J Physiol (Lond) 2004 558 (1 263 275.
15. Schumann A., Nutten S., Donnicola D., et al. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics 2005 23 (2 235 245.
16. Shi HN, Walker A. Bacterial colonization and the development of intestinal defences. Can J Gastroenterol 2004 18 (8 493 500.
17. Matricardi PM. Prevalence of atopy and asthma in eastern versus western Europe: why the difference Ann Allergy Asthma Immunol 2001 87 (6 suppl 3 24 27.
18. Brugman S., Klatter FA, Visser JT, et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes Diabetologia 2006 49 (9 2105 2108.
19. Schwartz RF, Neu J., Schatz D., Atkinson MA, Wasserfall C. Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes Diabetologia 49 : 2105 2108. Diabetologia 2007; 50 (1 220 221.
20. Vanderhoof JA, Young RJ. The role of probiotics in the treatment of intestinal infections and inflammation. Curr Opin Gastroenterol 2001 17 (1 58 62.
21. Bin-Nun A., Bromiker R., Wilschanski M., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005 147 (2 192 196.
22. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005 115 (1 1 4.
23. Kalliomaki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001 357 (9262 1076 1079.
24. Backhed F., Ding H., Wang T., et al. The gut microbiota as an environmental factor that regulates fat storage PNAS 2004 101 (44 15718 15723.
25. Hanson LA, Korotkova M., Lundin S., et al. The transfer of immunity from mother to child. Ann N Y Acad Sci 2003 987 (1 199 206.
26. Odijk J., Kull I., Borres MP, et al. Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations Allergy 2003 58 (9 833 843.
27. Field CJ. The immunological components of human milk and their effect on immune development in infants. J Nutr 2005 135 (1 1 4.
28. Zhang L., Li N., Caicedo R., Neu J. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr 2005 135 (7 1752 1756.
29. Land MH, Rouster-Stevens K., Woods CR, Cannon ML, Cnota J., Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005 115 (1 178 181.
30. Kunz AN, Fairchok MP, Noel JM. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005 116 (2 517.
31. De Groote MA, Frank DN, Dowell E., Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005 24 (3 278 280.
32. Riquelme AJ, Calvo MA, Guzman AM, et al. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin Gastroenterol 2003 36 (1 41 43.
33. Rijnders BJ, Van Wijngaerden E., Verwaest C., Peetermans WE. Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host. Intensive Care Med 2000 26 (6 825.
34. Rachmilewicz D., Katakura K., Karmeli F., et al. Tolllike receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004 126 (2 520 528.
35. Katakura K., Lee J., Rachmilewitz D., Li G., Eckmann L., Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005 115 (3 695 702.